Zhang Bo, Safa Rukhsana, Rusciano Dario, Osborne Neville N
Nuffield Laboratory of Ophthalmology, Walton Street, Oxford OX2 6AW, UK.
Brain Res. 2007 Jul 23;1159:40-53. doi: 10.1016/j.brainres.2007.05.029. Epub 2007 May 26.
The aim of this study was to examine whether the antioxidant epigallocatechin gallate (EGCG), a catechin-base flavonoid derived from green tea protects retina neurones in situ from ischemia/reperfusion and in vitro from an oxidative stress insult of hydrogen peroxide (H(2)O(2)). Similar results were obtained when rats were injected by two different regimes of EGCG. Ischemia was delivered by raising the intraocular pressure above the systolic blood pressure (120 mm Hg) generally for 45 min. The electroretinogram (ERG) was measured prior to ischemia and 5 days after reperfusion. Rats were killed 7 days after ischemia and processed for immunohistochemistry and for determining of mRNA and protein levels by RT-PCR and electrophoresis/western blotting, respectively. In addition, optic nerves 7 days after ischemia were subjected to protein analysis. Ischemia/reperfusion caused a significant reduction in the a- and b-wave amplitudes of the ERGs, a decrease in retinal ganglion cell and photoreceptor specific proteins and mRNAs, an increase in retinal caspase-3 mRNA and protein, an increase in retinal caspase-8 mRNA, an increase in retinal GFAP protein and mRNA and a decrease in optic nerve proteins associated with ganglion cell axons. All these changes were significantly counteracted by EGCG. Moreover, EGCG clearly blunted ischemia/reperfusion-induced changes in the localisation of retinal Thy-1 and ChAT immunoreactivities. EGCG also significantly reduced the apoptosis to retinal ganglion cells (RGC-5 cells) in culture caused by H(2)O(2). The results of the study demonstrate that EGCG provides protection to retinal neurones from oxidative stress and ischemia/reperfusion.
本研究的目的是检验抗氧化剂表没食子儿茶素没食子酸酯(EGCG),一种源自绿茶的儿茶素类黄酮,是否能在原位保护视网膜神经元免受缺血/再灌注损伤,并在体外保护其免受过氧化氢(H₂O₂)氧化应激损伤。当用两种不同的EGCG给药方案注射大鼠时,获得了相似的结果。通过将眼内压升高至收缩压以上(120 mmHg)来诱导缺血,通常持续45分钟。在缺血前和再灌注后5天测量视网膜电图(ERG)。缺血7天后处死大鼠,分别进行免疫组织化学检测以及通过逆转录聚合酶链反应(RT-PCR)和电泳/蛋白质印迹法测定mRNA和蛋白质水平。此外,对缺血7天后的视神经进行蛋白质分析。缺血/再灌注导致ERG的a波和b波振幅显著降低,视网膜神经节细胞和光感受器特异性蛋白质及mRNA减少,视网膜半胱天冬酶-3 mRNA和蛋白质增加,视网膜半胱天冬酶-8 mRNA增加,视网膜胶质纤维酸性蛋白(GFAP)蛋白质和mRNA增加,以及与神经节细胞轴突相关的视神经蛋白质减少。所有这些变化均被EGCG显著抵消。此外,EGCG明显减弱了缺血/再灌注诱导的视网膜Thy-1和胆碱乙酰转移酶(ChAT)免疫反应性定位的变化。EGCG还显著减少了由H₂O₂引起的培养的视网膜神经节细胞(RGC-5细胞)的凋亡。该研究结果表明,EGCG可保护视网膜神经元免受氧化应激和缺血/再灌注损伤。